Back
HFA Premium Access

Essential care following incident heart failure: a population-based study of diagnostic tests, drug prescriptions and follow-up patterns in 93,000 patients

Session: Late breaking trial IV - Registries
Topic: Treatment, Other
Speaker: Doctor N. Conrad (Leuven, BE)
Event: Heart Failure 2018

Congress Presentation

About the speaker

Doctor Nathalie Conrad

University of Leuven, Leuven (Belgium)
4 presentations
0 follower

11 more presentations in this session

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Speaker: Doctor Y. Khariton (Kansas City, US)

Access
Slides
Video
Thumbnail

Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF

Access
Video
Thumbnail

Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

Speaker: Professor D. Kotecha (Birmingham, GB)

Access
Slides
Video
Thumbnail

Discussion - ARM-CAD

Access
Video
Thumbnail

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

Speaker: Professor K. Branch (Seattle, US)

Access
Slides
Video
Thumbnail

Access the full session

Late breaking trial IV - Registries

Speakers: Doctor N. Conrad, Doctor Y. Khariton, Professor D. Kotecha, Professor K. Branch
Access
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb